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Technoscientifi c projects feature high 
on the Chinese government’s agenda. 
The decoding of the rice, chicken and 
most recently panda genomes have 
caught the attention of the media and 
the masses. A no less ambitious plan is 
the drive to establish China as a key force 
in human embryonic stem cell (hESC) 
research. While in the West hESC research 
has been slowed by ethical and legal 
debates, a highly permissive regulatory 
environment has been fostered in China. 
Achim Rosemann investigates how 
this corresponds to the perceptions of 
potential embryo donors.
Achim Rosemann
Asia is a force to be reckoned with when it comes to research in the life sciences. Asian countries play a major 
role both in shaping international research practices and in the formulation of bioethical research regulation 
in the fi eld of biomedical research and research applications, including stem cell research, genetic testing 
and screening, reproductive technologies and the banking of biological materials. Not only wealthy welfare 
societies such as Japan and Singapore but also large developing countries such as China and India, are strong 
global competitors at the forefront of biomedical research and biotech applications. These new fi elds of 
research, on the one hand, promise to yield revolutionary technologies and biomedical knowledge that 
could enhance the health and welfare of large patient populations, including diabetes, muscular dystrophy, 
Parkinson’s disease and Alzheimer’s disease. On the other hand, bioethical concerns have come about due 
to the novel and global nature of research in the life sciences and the application of resultant technologies 
in some regions where even the most basic healthcare is a scarce good.
Margaret Sleeboom-Faulkner
IN MANY FIELDS HOWEVER, biomedical knowledge has indeed 
contributed to the ability of researchers and doctors to alleviate, 
what is regarded as, the genetic burden of population groups 
at risk of certain genetic syndromes including sickle cell disease 
and thalassaemia (see Patra p.22, Sui p.23). Furthermore, the 
ability to sample and store genetic data together with informa-
tion on personal life style, disease history and environment, has 
contributed to new epidemiological insights into the aetiology 
of medical and genetic syndromes. Despite these benefi ts, the 
development of these new forms of research and its applications 
are accompanied by old and new social, fi nancial, and political 
problems, some of which take on particular forms in Asia. 
These problems occur exactly as a result of using new diagnostic 
technologies and linking personal health data to people’s genetic 
and biological make-up. Illustrative cases discussed in this 
special issue of the Newsletter relate to: the increasing need 
for therapies; social stigma; changing life values; the increased 
value of biological materials; the need for bioethical procedures; 
and international research collaboration. 
The ‘therapeutic gap’
The growing ability and practice of diagnosing and predicting 
diseases, such as Huntington’s Disease and various forms of 
cancer, makes it a moral imperative to provide genetic counsel-
ling and, if possible, therapy to patients diagnosed positive. 
For instance, in the case of genetically inherited syndromes such 
as sickle cell disease and thalassaemia, diagnosis should ideally 
be followed by therapy or medication. Where there is no or little 
access to healthcare facilities post-diagnosis, we speak of the 
‘therapeutic gap’. The widespread existence of the therapeutic 
gap places a moral question mark behind the not-well-thought-
through application of diagnostic technologies on carrier 
populations. Another problem also associated with careless 
diagnostic applications is that of social stigma, discussed in this 
special issue by Prasanna Patra in connection with sickle cell 
screening in India, by Suli Sui in relation to thalassaemia in China 
and by Masae Kato in connection with amniocentesis in Japan. 
When it becomes known that members of certain communities 
or families have a high prevalence of a certain genetic syndrome, 
varyingly associated with impurity, sin and uncouth behaviour, 
CHINESE AND OTHER EAST ASIAN political leaders have 
repeatedly pointed out that religion-based scruples such as 
those dominating Western debates on using human embryos 
in research do not exist in their societies (Sleeboom-Faulkner 
and Patra 2008). In China, to some extent at least, such ideas 
are refl ected also among philosophers and bioethicists. 
According to Ren-zong Qiu (2007), for example, the Confucian-
based view that a person comes into being only at the moment 
of birth, is still valid. The human embryo, from this perspective, 
is a betwixt and between entity. It is neither a person, with 
corresponding moral status, nor is it inanimate matter, without 
any moral status. For Qiu, therefore, the embryo is best 
described as a precursory person: a form of human biological 
life that deserves due respect. At the same time, however, 
it can be manipulated or destroyed if there is suffi  cient reason. 
From the perspective of Qiu and other bioethicists in China, 
such reason is amply justifi ed by the huge therapeutic potential 
of hESC research.
A less philosophical explanation for the permissive regulatory 
approach to hESC research in China has been provided by a 
number of Western observers, who have linked the widespread 
support for hESC research to the one-child policy. Cookson 
(2005), for example, has assumed that as a result of the high 
number of abortions carried out during the last three decades 
in the context of the family planning policies, embryonic forms 
of human life are generally held to be of low value in China. 
Therefore, a permissive regulatory environment would be 
easily introduced.
A striking feature that unites these diverging assumptions 
is that they are formulated in the complete absence of those 
who are actually confronted with the decision to donate their 
embryos: women and couples undergoing IVF treatment. 
What value do these people ascribe to their embryos and 
what are the culturally mediated assumptions and concerns 
that impact their decision to refuse or accept donation of their 
embryos? These are the questions that I shall address here 
on the basis of data gathered during fi eldwork conducted in 
February and March 2008 in two IVF clinics in South East and 
Central China, and on a survey carried out at that time among 
74 patients of IVF clinics and a control group of 426 students 
from two universities in Central China. The survey included 
multiple choice and open-ended questions to which 
respondents could provide handwritten comments.
 
Narratives of life, value and death 
Research fi ndings indicate that attitudes among embryo 
donors are much more varied and complex than the three 
perspectives introduced above suggest. The notion, for 
example, that ethical scruples regarding the use of human 
embryos do not exist in China cannot be upheld. Although 
the overwhelming majority of survey participants regarded 
hESC research as making meaningful contributions to medicine 
and science, only 45.7% of all respondents of the survey said 
they would actually agree to the donation of their embryos for 
hESC research, while 53.4% indicated that they would refuse 
to donate (0.9% were undecided).      
Among this last group, 52.9% (28.8% of all respondents) 
rationalised their refusal by supporting the statement that 
‘using the embryo is the same as consuming a life’ – an 
assertion that echoes one of the key complaints against hESC 
research in Western societies. The issue was qualifi ed in 
several of the survey respondents’ handwritten comments:
“To donate an embryo to research is equal to killing a life. 
I think life cannot be destroyed casually”. 
(Student, Medicine, female, 25)
“It is a moral matter. The embryo is also a life and has its 
right to live”. (Student, Medicine, male, 21)
An underlying reason for the widespread support of the notion 
that using an embryo for hESC research is equivalent to termi-
nating a human life might be that the large majority of survey 
respondents conceive the starting point of the life of a human 
being to be located in the initial phase of embryogenesis. For 
instance, in reply to the question ‘When do you think the life 
of a human being starts?’ 56.8% of all respondents selected the 
option ‘at the moment of fertilisation’, while another 31.4% 
opted for ‘when a fertilised egg cell has evolved to an embryo’. 
Only 6.9% of all respondents envisioned the starting point of 
the life of a human being to be situated at a later phase during 
gestation (3.3% opted for ‘the development of the nerve system’ 
and 3.6% for ‘the development of organs’) and only 3.9% 
endorsed the view that the life of a human being would start 
at the moment of birth (1.0% of the total were undecided).
These fi ndings suggest that lines of ethical reasoning that 
depart from the Confucian idea that a person comes into 
existence only at the moment of birth do not correspond to 
the perceptions of the overwhelming majority of potential 
embryo donors in China. Accordingly, ethical debates or regula-
tions that are based on this view fall short in accounting for the 
actual perceptions and needs of the people confronted with the 
decision to donate their embryos. That perspectives on early 
forms of human life in China are much more complex than has 
been commonly suggested is confi rmed also by Jing-bao Nie’s 
(2005) study on the viewpoints of people in China on abortion, 
which arrives at quite similar conclusions.
 
Assessing emotional consequences
A more nuanced assessment of the subjective and embodied 
perspectives of the women confronted with the request to 
give away their supernumeral embryos came to the fore also 
in the responses to survey questions. Thus, 31.4% of all respon-
dents endorsed the statement that they would ‘expect some 
psychological or emotional diffi  culties after donation’. And a 
subgroup of 37.9% of the 293 respondents who had specifi ed 
that they would refuse to donate their embryos indicated that 
the underlying reason for their decision was ‘fear of emotional 
or psychological consequences in case of donation’ (these are 
20.2% of all survey respondents). Such fears were refl ected 
also in several of the handwritten comments: 
“It [embryo donation] may have consequences for people 
in a spiritual and psychological sense. Also, it may bring 
confl icts with morals and ethics”. 
(Student, Chinese Literature, female, 23)
“It may hurt mentally the person who donates”. 
(Student, Computer Science, male, 21)
That women are likely to build up a strong emotional bond with 
their embryos can also be seen from the following excerpt of 
an interview with an IVF patient. Just before our conversation, 
the women had heard that she had become pregnant:
“I want to keep these [frozen surplus] embryos for a long time. 
I really cannot consider giving them away now. Maybe later, 
when my child is four or fi ve years old… but also then I would 
not like to give them all away. I still would like to keep some”.
(IVF patient, 29)
entire households run the risk of becoming ostracised by the 
community. In such cases, the blaming of women for producing 
unworthy off spring is especially widespread. 
When predictive testing leads to abortion, this can lead to 
a change in life values. This development is illustrated in Masae 
Kato’s case study of the women’s and handicapped people’s 
movements in Japan, relating how groups of disabled people 
feel discriminated against when the abortion of foetuses with 
‘their’ handicap becomes normalised. They experience this as 
a degradation of their lives. While women in Japan may believe 
they choose for abortion, Jyotsna Gupta’s study on prenatal 
testing in India shows how, although the possibility of having 
an abortion empowers women, they may have no choice other 
than to have an abortion when opposition exists to raising a girl 
or an ‘imperfect’ child. Another issue related to the valuation 
of human life is exemplifi ed by Suli Sui’s case study of thalas-
saemia, which shows how parents of children with this disorder 
in China feel about giving birth to a ‘saviour sibling’. Such 
dilemmas raise questions about what life people fi nd worth 
supporting, a question also answered diff erently within Asia, 
with its rich cultural, political and religious variety. 
Regulating bioethics
When life scientists started to collect, store and export 
biological materials from Asian countries on a large scale in 
the mid 1990s, including human tissues and DNA, the practice 
of taking people’s samples became very controversial, after 
which its export has been regulated by Asian governments. 
At the same time, most Asian countries involved in the life 
sciences introduced bioethical regulation for sample taking 
to follow due ethical procedures, including informed consent. 
The taking and storing of biological materials, such as human 
DNA, reproductive materials, and umbilical cord blood, for the 
purpose of research or therapy, however, does not always take 
into account due procedure, as is shown by Jan-Eerik Leppanen’s 
report of DNA sampling for the ethnic biobank in Kunming in 
Southwest China. An additional problem faced by developing 
countries, as shown by Robert Simpson et al’s discussion of 
bioethical review in South Asia, is that the implementation 
of bioethical procedures requires an institutional set up 
that can be expensive, labour intensive, and therefore hard 
to maintain.
The new developments of research and applications in the 
life sciences, then, are accompanied by a concern that new 
opportunities have come about for the exploitation of vulner-
able people. This does not only refer to the use of or trade in 
human organs, genetic material, human tissues or information 
based on biomaterials, but also to the use of reproductive 
materials such as human ova, embryos and foetuses in human 
embryonic and foetal stem cell research. Seyoung Hwang and 
Leo Kim describe diff erent aspects of the Hwang Woo-Suk 
scandal in South Korea that revealed how this well-known 
stem cell scientist used the ova of female laboratory assistants. 
Seyoung Hwang shows that the role of the public in discussions 
on bioethical regulation of stem cell science was hardly taken 
seriously in South Korea’s quest to forge ahead in the fi eld; and 
Leo Kim’s account of a Parliamentary Life Science Research 
Forum illustrates how the ‘global war’ in stem cell science is 
emphasised over potential local harm. 
Studies on bioethics in Asian societies indicate that life values 
are changing and vary from country to country. Together with 
the divergent ability of diff erent countries to set up bioethics 
institutions, the variety in culture and development has far-
reaching implications for the bioethical standards in international 
science collaborations, especially when countries with relatively 
permissive regulation become attractive to countries with 
relatively strict regulation. Contributing researchers of both the 
Socio-genetic Marginalisation in Asia Programme (SMAP), Leiden 
and the International Science and Bioethics Collaboration project 
(Cambridge, Durham and Sussex Universities) have tried to shed 
light on these implications, in the hope that bioethical problems 
will be duly acknowledged, recognised and addressed. 
Margaret Sleeboom-Faulkner
Project Director, SMAP
University of Sussex, UK
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Discussion
These fi ndings suggest that attitudes and perceptions of 
the value and of the permissibility to donate and use human 
embryos for hESC research are much more varied and complex 
in China than is commonly suggested. The research partici-
pants’ responses made clear that Confucian-based ideas on 
the starting point of human life signifi cantly mismatch with the 
actual perceptions of potential embryo donors; it also became 
clear that arguments proclaiming that moral concerns regard-
ing the donation of embryos for research are absent in China 
cannot be upheld. Equally fl awed appears the assumption that 
due to the high number of abortions carried out in the context 
of the one-child policy, the value of early forms of human life 
are generally of low regard among Chinese people. Instead, 
as the fi ndings of this study suggest, perceptions of embryonic 
life in China, as elsewhere, are entangled in a rich web of 
overlapping and sometimes contradictory layers of meaning, 
values, emotions and social relations of which analysts, policy 
makers, scientists and clinical staff  are insuffi  ciently aware. 
Achim Rosemann
University of Sussex, UK 
ar253@sussex.ac.uk
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